F. Marc Stewart, M.D.

800-826-4673
F. Marc Stewart, M.D.
Hematologist-Oncologist
Clinical Expertise
  • Hematology
  • Leukemia
  • Lymphoma
Research Area
  • Hematology and Hematopoietic Cell Transplantation
  • Leukemia
Academic Appointments
  • Chief Medical Officer for City of Hope Los Angeles and the Los Angeles Clinical Network Sites
Clinical Teams
Hematology & Hematopoietic Cell Transplantation
Leukemia
"Becoming a part of an organization that conducts outstanding research and advances care for cancer patients is a real privilege."
F. Marc Stewart, M.D., says you’re likely to hear him before you see him. He’s known for whistling through the halls as he makes his rounds, a habit picked up from his physician-grandfather, whom he’d follow around as a 10-year-old. It’s also where he learned empathy, compassion and respect. “What I witnessed as I tagged along behind my grandfather in that small town hospital made medicine an easy career choice for me,” he says. “His example has greatly influenced the way I relate to patients, their family members and my colleagues.”
 
Dr. Stewart brings four decades of superlative experience and leadership to City of Hope. He served for two decades as medical director of Seattle Cancer Care Alliance at Fred Hutchinson Cancer Research Center. He held similar leadership roles at University of Massachusetts and University of Virginia.
 
A native of Indiana, Dr. Stewart received his medical degree from Indiana University School of Medicine, Indianapolis, where he also completed his residency and oncology fellowship. 
 
Dr. Stewart’s research interests include the biology of engraftment (when transplanted blood cells begin to multiply and recover), cellular immunotherapy (using the body’s immune cells to attack cancer), drug safety and health care delivery. He’s excited to be part of the City of Hope family. “I view my opportunity to work here helping patients as a true honor,” he said.

Location

Education & Experience

Board Certifications

  • 1986, Oncology

  • 1982, Hematology

  • 1980, American Board of Internal Medicine

Degrees

  • 1977, M.D., Indiana University School of Medicine, Indianapolis, Indiana

  • 1974, A.B., Chemistry, Indiana University, Bloomington, Indiana

Fellowship

  • 1981-1983, Hematology, University of Virginia, Charlottesville, Virginia

  • 1980-1981, Oncology, Indiana University Hospitals, Indianapolis, Indiana

Residency

  • 1978-1980, Medicine, Indiana University Hospitals, Indianapolis, Indiana

Internship

  • 1977-1978, Medicine, Bridgeport Hospital, Bridgeport, Connecticut (Yale University)

Professional Experience

  • 2024-present, Chief Medical Officer for City of Hope Los Angeles and the Los Angeles clinical network sites

  • 2020-present, Professor, Emeritus, University of Washington, Department of Medicine

  • 2020-2024, Professor and Vice Chair, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, California

  • 2017-2020, Senior Vice President, Seattle Cancer Care Alliance

  • 2000-2020, Medical Director, Seattle Cancer Care Alliance

  • 2000-2020, Professor of Medicine, University of Washington

  • 2013-2016, Acting Head, Division of Medical Oncology, Department of Medicine, University of Washington

  • 2000, Vice Chair for Affiliate Relations, Department of Medicine, University of Massachusetts Medical Center

  • 1998-2000, Professor of Medicine and Cell Biology, University of Massachusetts Medical Center

Awards & Memberships

Awards

  • 2018, Outstanding Medical Director Award, Seattle Business Magazine

  • 2008, University of Washington Service Excellence Award, Summer

  • 2007, Meritous Service Award, National Patient Advocate Foundation

Memberships

  • 1992-2000, Principle Investigator, University of Massachusetts, CALGB (Cancer and Acute Leukemia Group B)

  • 1994-1996, Secretary-Treasurer, American Association of Hematology/Oncology Program Directors

  • 1999-2000, Member, Executive Committee, CALGB (Cancer and Acute Leukemia Group B)

  • 2000-2003, Chair, Hematology Section, Cancer Education Committee, American Society of Clinical Oncology

  • 2002-2005, Member, Cancer Education Committee, American Society of Clinical Oncology

  • 2002, Member, Board of Directors, National Comprehensive Cancer Network

  • 2002, Member, Executive Committee, National Comprehensive Cancer Network

  • 2002, Co-Chair, Best Practices Committee, National Comprehensive Cancer Network

  • 2002, Member, Guidelines Steering Committee, National Comprehensive Cancer Network

  • 2003-2004, Member, Scholar Award Study Section, American Society of Hematology

  • 2004-2007, Member, Committee on Education Affairs, American Society of Hematology

  • 2005-2019, Member, Board of Directors, National Patient Advocate Foundation

  • 2014-2017, President, National Patient Advocate Foundation

  • 1984-1985, Secretary-Treasurer, Virginia Society of Hematology and Oncology

  • 1984-1985, President Elect, Virginia Society of Hematology and Oncology

  • 1985-1986, President, Virginia Society of Hematology and Oncology

  • 2001-2009, Member, Puget Sound Oncology Consortium

  • 2001-Present, Member, Southwest Oncology Group

  • 2004-2006, Member, Board of Trustees, Washington State Medical Society

Publications

  • Ueda, M, Martins R, Hendrie P, McDonnell T, Crews J, Wong T, McCreery B, Jagels B, Crane A, Byrd D, Pergam S, Davidson N, Liu C, Stewart FM. Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal. J Natl Compr Canc Netw. 2020;Mar 20:1-4. doi: 10.6004/jnccn.2020.7560. Online ahead of print. PMID: 32197238
  • Poston J, Sugalski J, Gernsheimer T, Stewart FM, Pagano M. Mitigation Strategies for Anti-D Alloimmunization by Platelet Transfusion in Hematopoietic Stem Cell Transplant Patients: a Survey of NCCN centres. Vox Sang. 2020;May;115(4): 334-338. doi: 10.1111/vox.12899. Epub 2020 Feb 20. PMID: 32080868
  • Oshima MU, Sandmaier BM, Petersdorf E, Flowers ME, Hill GR, Lee SJ, Appelbaum FR, Carpenter PA, Baker KS, Connelly-Smith L, McCool A, Elgar S, Pergam SA, Liu C, Stewart FM, Mielcarek M. Blood and marrow transplantation during the emerging COVID-19 pandemic: the Seattle approach. Bone Marrow Transplant. 2021;56(2):305-313. PMID: 32980860 PMCID: PMC7519858
  • Marquis SR, Logue JK, Chu HY, Loeffelholz T, Quinn ZZ, Liu C, Stewart FM, Carpenter PA, Pergam SA, Krantz EM. Seroprevalence of Measles and Mumps Antibodies Among Individuals With Cancer. JAMA Netw Open. 2021;Jul 1;4(7):e2118508. doi: 10.1001/jamanetworkopen.2021.18508. PMID: 34319355 PMCID: PMC8319758
  • Aldoss I, Yang D, Gu Z, Tomasian V, Mokhtari S, Jackson R, Telatar M, Yew H, Al Malki M, Salhotra A, Khaled S, Ali H, Aribi A, Sandhu K, Mei M, Arslan S, Koller P, Artz A, Aoun P, Gu D, Snyder D, Stewart FM, Curtin P, Stein A, Pillai R, Marcucci G, Forman SJ, Pullarkat V, Nakamura R, Afkhami M. Outcomes of Allogeneic Hematopoietic Cell Transplantation in Adults with Ph-like ALL. Blood. (2021) 138 (Supplement 1): 3955.PMID:35816633
  • Aldoss I, Otoukesh S, Zhang J, Mokhtari S, Ngo D, Mojtahedzadeh M, Al Malki M, Salhotra A, Ali H, Aribi A, Sandhu KS, Arslan S, Koller P, Ball B, Stewart FM, Curtin P, Artz A, Nakamura R, Marcucci G, Forman SJ, Stein AS, Pullarkat V. Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia. Cancer 2022 Feb 1;128(3):529-535. PMID:34633671
  • Aldoss I, Yang D, Tomasian V, Mokhtari S, Jackson R, Gu Z, Telatar M, Yew H, Al Malki MM, Salhotra A, Khaled S, Ali H, Aribi A, Sandhu KS, Mei M, Arslan S, Koller P, Artz A, Aoun P, Gu D, Snyder D, Stewart FM, Curtin P, Stein AS, Pillai R, Marcucci G, Forman SJ, Pullarkat V, Nakamura R, Afkhami M. Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL. Blood Adv. 2022 Sep 13;6(17):4936-4948 PMID: 35816633
  • Kulkarni P, Mohanty A, Bhattacharya S, Singhal S, Guo L, Ramisetty S, Mirzapoiazova T, Mambetsariev B, Mittan S, Malhotra J, Gupta N, Kim P, Babikian R, Rajurkar S, Subbiah S, Tan T, Nguyen D, Merla A, Kollimuttathuillam S, Phillips T, Baik P, Tan B, Vashi P, Shrestha S, Leach B, Garg R, Rich P, Stewart FM, Pisick E, Salgia R. Addressing Drug Resistance in Cancer: A Team Medicine Approach. J. Clin. Med. 2022 Sept. 27;11(19), 5701 PMID: 36233569
  • Agrawal V, Pourhassan H, Tsai NC, Ngo D, Koller P, Malki MMA, Salhotra A, Ali H, Aribi A, Sandhu KS, Arslan S, Ball B, Otoukesh S, Amanam I, Artz A, Singh D, Becker PS, Stewart FM, Smith EP, Curtin P, Stein AS, Marcucci G, Forman SJ, Nakamura R, Pullarkat V, Aldoss I. Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab. Transplant Cell Ther. 2023 May;29(5):314-320. Doi: 10.1016/j.jtct.2023.01.017. Epub 2023 Jan 19 PMID: 36682470
  • Aldoss I, Afkhami M, Yang D, Gu Z, Mokhtari S, Shahani S, Pourhassan H, Agrawal V, Koller P, Arslan S, Tomasian V, Al Malki MM, Artz A, Salhotra A, Ali H, Aribi A, Sandhu KS, Ball B, Otoukesh S, Amanam I, Becker PS, Stewart FM, Curtin P, Smith E, Telatar M, Stein AS, Marcucci G, Forman SJ, Nakamura R, Pullarkat V. High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusions. Am J Hematol. 2023 Jun;98(6)L848-856. Doi: 10.1002/ajh.26908. Epub 2023 Mar 19. PMID: 36880203
  • Al Malki MM, Yao J, Otoukesh S, Kim H, Yang D, Mokhtari S, Samara Y, Blackmon A, Arslan S, Agrawal V, Pourhassan H, Amanam I, Ball B, Koller P, Salhotra A, Becker PS, Curtin P, Artz A, Aldoss I, Ali H, Stewart FM, Smith E, Stein A, Marcucci G, Forman SJ. Tocilizumab for Cytokine Release Syndrome Management after Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis. Transplant Cell Ther 2023 March online ahead of print.
  • Winckworth-Prejsnar K, Nardi EA, McCanney J, Stewart FM, Langbaum T, Gould BJ, Fitzgerald CL, Carlson RW. Ensuring Patient Safety and Access in Cancer Care. J Natl Compr Canc Netw. 2017 Dec;15(12):1460-1464. PMID: 29223983
  • Jacob Appelbaum; David Wells; Joseph B. Hiatt; Gideon Steinbach; F. Marc Stewart; Hannah Thomas; Paul Nghiem; Raj P. Kapur; John A. Thompson; Shailender Bhatia. Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: J Immunother Cancer. 2018 Aug 31;6(1):82. PMCID: PMC6117974
  • Jessica M. Sugalski, MPPA; Timothy Kubal, MD, MBA, Daniel L. Mulkerin, MD; Rebecca L. Caires, MBA; Penny J. Moore, MSN, RN, OCN, NEA-BC; Rosanna Fiorarancio Fahy; Jeanine N. Gordon, RN, MSN, OCN, NE-BC; Connie Z. Augustyniak, RN, BSN, OCN; Gina M. Szymanski, MS, RN; MiKaela Olsen, ARRN-CNS, MS, AOCNS; Diedra K. Frantz, RN, BSN; Marisa A. Quinn, RN, MBA; Sharol K. Kidd, RN; Diana M. Krause, MHA; Robert W. Carlson, MD; F. Marc Stewart, MD. National Comprehensive Cancer Network (NCCN®) Infusion Efficiency Workgroup Study: Optimizing Patient Flow in Infusion Centers: J Oncol Pract. 2019 May;15(5):e458-e466. doi: 10.1200/JOP.18.00563 Epub 2019 Apr 9. PMID: 30964732
  • Graf SA, Stewart FM: Early Warning Signs: In: Cancer: Prevention, Early Detection, Treatment and Recovery, Second Edition, Edited by Gary Stein and Kimberly Luebbers. John Wiley & Sons, Inc., 2019
  • Nandita Khera, Jessica Sugalski, Diana Krause, Richard Butterfield III, Nan Zhang, F. Marc Stewart, Robert W. Carlson, Joan M. Griffin, Yousuf Zafar, Stephanie Lee. Current Practices for Screening and Management of Financial Distress at NCCN Member Institutions.  J Natl Compr Canc Netw. 2020 Jul;18(7): 825-831. PMID: 32634772
  • Hill JA, Vande Vusse L, Xie H, Chung EL, Yeung C, Seo S, Stevens-Ayers T, Fisher C, Huang ML, Stewart FM, et al. Human Herpesvirus 6B and Lower Respiratory Tract Disease after Hematopoietic Cell Transplantation. J Clin Oncol. 2019 Oct 10;37(29): 2670-2681 doi: 10.1200/JCO.19.00908. Epub 2019 Aug 26. PMCID: PMC7351330
  • Ueda, M, Martins R, Hendrie P, McDonnell T, Crews J, Wong T, McCreery B, Jagels B, Crane A, Byrd D, Pergam S, Davidson N, Liu C, Stewart FM. Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal. J Natl Compr Canc Netw. 2020 Mar 20; 1-4. doi: 10.6004/jnccn.2020.7560. Online ahead of print. PMID: 32197238
  • Poston J, Sugalski J, Gernsheimer T, Stewart FM, Pagano M. Mitigation Strategies for Anti-D Alloimmunization by Platelet Transfusion in Hematopoietic Stem Cell Transplant Patients: a Survey of NCCN centres. Vox Sang. 2020 May;115(4): 334-338. doi: 10.1111/vox.12899. Epub 2020 Feb 20. PMID: 32080868

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.